Anthony P. Schwarer

6.3k total citations · 1 hit paper
119 papers, 3.3k citations indexed

About

Anthony P. Schwarer is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Anthony P. Schwarer has authored 119 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Hematology, 45 papers in Genetics and 31 papers in Immunology. Recurrent topics in Anthony P. Schwarer's work include Hematopoietic Stem Cell Transplantation (41 papers), Chronic Myeloid Leukemia Treatments (38 papers) and Chronic Lymphocytic Leukemia Research (36 papers). Anthony P. Schwarer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (41 papers), Chronic Myeloid Leukemia Treatments (38 papers) and Chronic Lymphocytic Leukemia Research (36 papers). Anthony P. Schwarer collaborates with scholars based in Australia, United States and United Kingdom. Anthony P. Schwarer's co-authors include Andrew Grigg, Timothy P. Hughes, John F. Seymour, Jeff Szer, Susan Branford, Christopher Arthur, Robin Filshie, Monica A. Slavin, Anthony K. Mills and David M. Ross and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Anthony P. Schwarer

113 papers receiving 3.2k citations

Hit Papers

Safety and efficacy of im... 2013 2026 2017 2021 2013 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anthony P. Schwarer 2.1k 1.1k 886 656 591 119 3.3k
Bethanie Wilkinson 1.2k 0.6× 715 0.6× 890 1.0× 2.2k 3.4× 744 1.3× 36 3.7k
Jenny Byrne 2.2k 1.0× 853 0.8× 416 0.5× 379 0.6× 1.0k 1.8× 124 3.1k
Juan Carlos Hernández‐Boluda 1.8k 0.9× 1.7k 1.6× 253 0.3× 761 1.2× 523 0.9× 167 3.1k
Nicolaas Schaap 2.1k 1.0× 794 0.7× 1.9k 2.2× 230 0.4× 1.5k 2.5× 152 4.6k
Agnès Devergie 2.1k 1.0× 485 0.4× 800 0.9× 162 0.2× 627 1.1× 55 3.0k
Anna Maria Raiola 2.4k 1.2× 634 0.6× 910 1.0× 137 0.2× 1.2k 2.0× 118 3.8k
Sébastien Maury 1.8k 0.9× 481 0.4× 1.1k 1.2× 164 0.3× 1.1k 1.8× 125 3.7k
Roshini S. Abraham 1.2k 0.6× 704 0.6× 1.7k 1.9× 232 0.4× 619 1.0× 126 4.4k
G J Mufti 2.8k 1.4× 988 0.9× 1.0k 1.1× 168 0.3× 1.4k 2.4× 119 4.8k
Pascal Turlure 2.1k 1.0× 955 0.9× 384 0.4× 338 0.5× 664 1.1× 113 3.2k

Countries citing papers authored by Anthony P. Schwarer

Since Specialization
Citations

This map shows the geographic impact of Anthony P. Schwarer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony P. Schwarer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony P. Schwarer more than expected).

Fields of papers citing papers by Anthony P. Schwarer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony P. Schwarer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony P. Schwarer. The network helps show where Anthony P. Schwarer may publish in the future.

Co-authorship network of co-authors of Anthony P. Schwarer

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony P. Schwarer. A scholar is included among the top collaborators of Anthony P. Schwarer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony P. Schwarer. Anthony P. Schwarer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chee, Lynette, Nora Lee, Andrew Grigg, et al.. (2024). Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia. Internal Medicine Journal. 54(7). 1214–1218. 2 indexed citations
2.
Pagani, Ilaria S., Chung Hoow Kok, Verity A Saunders, et al.. (2017). A Method for Next-Generation Sequencing of Paired Diagnostic and Remission Samples to Detect Mitochondrial DNA Mutations Associated with Leukemia. Journal of Molecular Diagnostics. 19(5). 711–721. 6 indexed citations
3.
Hughes, Timothy P., Brian Leber, Francisco Cervantes, et al.. (2017). Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results. Leukemia. 31(11). 2529–2531. 31 indexed citations
4.
Ghasemzadeh, Mehran, Ehteramolsadat Hosseini, Anthony P. Schwarer, & Ali Akbar Pourfathollah. (2015). NK cell maturation to CD56dim subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation. Leukemia Research. 43. 58–65. 17 indexed citations
5.
Hosseini, Ehteramolsadat, Anthony P. Schwarer, & Mehran Ghasemzadeh. (2014). Do human leukocyte antigen E polymorphisms influence graft-versus-leukemia after allogeneic hematopoietic stem cell transplantation?. Experimental Hematology. 43(3). 149–157. 20 indexed citations
6.
Hughes, Timothy P., Gabriel Étienne, Cármino Antônio De Souza, et al.. (2012). Nilotinib induces deeper molecular responses vs continued imatinib in patients with ph+ chronic myeloid leukemia (CML) with detectable disease after ≥ 2 years on imatinib: ENESTcmr 12-months results. Haematologica. 97. 239–239.
7.
Fong, Chun Yew, George Grigoriadis, John Coutsouvelis, et al.. (2012). Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse. Leukemia & lymphoma. 54(2). 336–341. 12 indexed citations
10.
11.
Mullighan, Charles G., Susan L. Heatley, Kathleen Doherty, et al.. (2004). Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation. 77(4). 587–596. 71 indexed citations
12.
Slavin, Monica A., Andrew Grigg, & Anthony P. Schwarer. (2003). Fatal Anerobic Bacteremia after Hematopoietic Stem Cell Transplant. Leukemia & lymphoma. 45(1). 143–145. 2 indexed citations
13.
Hensel, Nancy F., Ken Bradstock, Anthony P. Schwarer, et al.. (2002). Flow cytometric quantitation and characterization of the T-lymphocyte memory response to CMV in healthy donors. Cytotherapy. 4(1). 29–40. 18 indexed citations
14.
Schwarer, Anthony P., et al.. (2000). A Randomized Trial of Leukapheresis Volumes, 7 L versus 10 L: An Assessment of Efficacy and Patient Tolerance. Journal of Hematotherapy & Stem Cell Research. 9(2). 269–274. 5 indexed citations
15.
Boogaerts, Marc, Gary Garber, D. J. Winston, et al.. (1999). Itraconazole (IT) compared with amphotericin B (AMB) as empirical therapy for persistent fever of unknown origin (FUO) in neutropenic patients (PTS). Bone Marrow Transplantation. 23. 9 indexed citations
16.
Schachna, Lionel, P. F. J. Ryan, & Anthony P. Schwarer. (1998). Malignancy-associated remission of systemic lupus erythematosus maintained by autologous peripheral blood stem cell transplantation. Arthritis & Rheumatism. 41(12). 2271–2272. 22 indexed citations
17.
Schwarer, Anthony P., et al.. (1997). Disseminated echovirus infection after allogeneic bone marrow transplantation. Pathology. 29(4). 424–425. 3 indexed citations
18.
Cullis, Jonathan, Richard Szydlo, Nicholas C.P. Cross, et al.. (1993). Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion.. PubMed. 11 Suppl 1. 107–11. 8 indexed citations
19.
Schwarer, Anthony P., Yawei Jiang, A. John Barrett, et al.. (1993). Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. The Lancet. 341(8839). 203–205. 105 indexed citations
20.
Marks, David I., Timothy P. Hughes, Richard Szydlo, et al.. (1992). HLA‐identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome. British Journal of Haematology. 81(3). 383–390. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026